Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 01 Apr 2006 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | SBI MNC Fund |
|---|---|
| 01 Apr 2006 | ₹100.00 |
| 13 Dec 2007 | ₹185.45 |
| 24 Aug 2009 | ₹113.93 |
| 07 May 2011 | ₹156.66 |
| 16 Jan 2013 | ₹195.77 |
| 29 Sep 2014 | ₹316.98 |
| 10 Jun 2016 | ₹382.87 |
| 21 Feb 2018 | ₹488.48 |
| 03 Nov 2019 | ₹513.02 |
| 16 Jul 2021 | ₹748.42 |
| 28 Mar 2023 | ₹787.23 |
| 08 Dec 2024 | ₹1071.38 |
| 20 Aug 2026 | ₹1175.61 |
| Metric | SBI · Regular NAV ₹414.52 Very High risk ★★★☆☆ | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +15.24% | +5.83% | |
| +8.45% | +15.63% | |
| +9.15% | +13.23% | |
| +11.36% | +13.85% | |
| +12.85% | +12.26% | |
| +10.13% | — | |
| +14.07% | +15.60% | |
| +14.45% | +14.52% | |
| +14.59% | +13.74% | |
| Risk | ||
| 11.65% | 15.62% | |
| 0.17 | 0.43 | |
| 0.23 | 0.59 | |
| -74.20% | -23.65% | |
| Nifty 500 | — | |
| -2.39% | +3.42% | |
| 0.76 | 0.95 | |
| 74.4% | 105.9% | |
| 80.1% | 93.6% | |
| 2.01% | 2.39% | |
| ₹5,534Cr | ₹1,161Cr | |
| 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 29% | 45% | |
| Pradeep Kesavan · 2.7y | — | |
| 01 Apr 2006 | — | |
| 43 | — | |
| 37.6% | — | |
| 1.3% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.